ANTI-ANGIOGENIC TARGETED DRUGS

Clinical trials for ANTI-ANGIOGENIC TARGETED DRUGS explained in plain language.

Never miss a new study

Get alerted when new ANTI-ANGIOGENIC TARGETED DRUGS trials appear

Sign up with your email to follow new studies for ANTI-ANGIOGENIC TARGETED DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo targets cancer spread to the brain

Disease control Not yet recruiting

This study is testing a combination of three drugs (utidelone, bevacizumab, and sometimes etoposide) to treat cancer that has spread to the brain from lung or breast tumors. It will involve 56 patients to see if this approach can shrink brain tumors and control the disease. The g…

Matched conditions: ANTI-ANGIOGENIC TARGETED DRUGS

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ANTI-ANGIOGENIC TARGETED DRUGS

Get alerted when new ANTI-ANGIOGENIC TARGETED DRUGS trials appear

New drug combo targets cancer spread to the brain